| PERIOD ENDING | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | 27-Sep-08 | | Total Revenue | 362,837 | 333,052 | 418,331 | 386,310 | | Cost of Revenue | 144,154 | 127,454 | 172,063 | 158,520 | | | Gross Profit | 218,683 | 205,598 | 246,268 | 227,790 | | | Operating Expenses | | Research Development | 19,722 | 18,332 | 19,628 | 19,946 | | Selling General and Administrative | 109,583 | 99,159 | 101,464 | 107,463 | | Non Recurring |
-
|
-
| 6,527 |
-
| | Others | 2,683 | 2,616 | 2,317 | 2,349 | | | | Total Operating Expenses |
-
|
-
| 129,936 |
-
| | | | Operating Income or Loss | 86,695 | 85,491 | 116,332 | 98,032 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 595 | 908 | 3,066 | 6,028 | | Earnings Before Interest And Taxes | 87,290 | 86,399 | 119,398 | 104,060 | | Interest Expense | 2,649 | 3,130 | 6,987 | 10,570 | | Income Before Tax | 84,641 | 83,269 | 112,411 | 93,490 | | Income Tax Expense | 14,734 | 9,922 | 13,058 | 21,987 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 69,907 | 73,347 | 99,353 | 71,503 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 69,907 | 73,347 | 99,353 | 71,503 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $69,907 | $73,347 | $99,353 | $71,503 |
|
2.03% Nasdaq 0.00%
Income Statement
